The global Anti Obesity Drug Market is experiencing robust growth as the prevalence of obesity continues to rise worldwide. According to recent estimates, the market was valued at USD 6.8 billion in 2022 and is projected to reach USD 15.2 billion by 2030, growing at a CAGR of 10.5% from 2023 to 2030.